Dihydroquercetin (taxifolin) is a naturally occurring flavonoid with remarkable potential in combating chronic inflammation and its related diseases. Found in sources like Siberian larch and certain fruits, this polyphenolic compound is gaining attention for its antioxidant, anti-inflammatory, and disease-preventive properties. In this article, we explore dihydroquercetin’s mechanisms of action, pharmacokinetics, and its unique role in ACEND, TRILITY’s flagship medical food designed to mitigate chronic inflammation and prevent disease onset.
Dihydroquercetin is classified as a small molecule, offering distinct advantages in therapeutic applications. Its small molecular size allows it to efficiently cross cellular membranes, including the blood-brain barrier. This property is particularly valuable in addressing neuroinflammation and protecting against neurodegenerative diseases like Alzheimer’s and Parkinson’s.
Dihydroquercetin’s therapeutic effects are largely driven by its ability to target inflammatory biomarkers and oxidative stress.
When ingested, dihydroquercetin undergoes transformation by gut microbiota, producing bioactive metabolites that amplify its anti-inflammatory effects.
Dihydroquercetin exhibits high bioavailability and a favorable pharmacokinetic profile. Once absorbed, it rapidly distributes to tissues, where it exerts its protective effects.
The ability of dihydroquercetin to cross the blood-brain barrier makes it a promising candidate for combating neurodegenerative diseases. By reducing oxidative stress and neuroinflammation, it helps protect against Alzheimer’s and Parkinson’s.
Dihydroquercetin enhances vascular function by reducing oxidative damage to endothelial cells and inhibiting the oxidation of LDL cholesterol, a major contributor to atherosclerosis.
Its anti-inflammatory and antioxidant properties help regulate blood sugar levels, improve insulin sensitivity, and reduce the risk of complications associated with metabolic syndrome and diabetes.
By modulating inflammation and supporting a balanced microbiome, dihydroquercetin plays a crucial role in managing IBD, Crohn’s disease, and IBS.
Incorporating dihydroquercetin into ACEND enhances the product’s ability to target chronic inflammation and related diseases. Its synergy with other ingredients in ACEND amplifies its benefits, offering a comprehensive approach to health and wellness.
Dihydroquercetin’s potent antioxidant and anti-inflammatory properties make it a cornerstone ingredient in the fight against chronic inflammation and its related diseases. Its inclusion in ACEND underscores TRILITY’s commitment to leveraging cutting-edge science to deliver effective solutions for health and longevity. By addressing inflammation at its root, dihydroquercetin not only alleviates symptoms but also prevents disease progression, making it an invaluable asset in the food-as-medicine movement.